from2028 Activists Investors Trump Politicians Serenity Citrini Burry Semianalysis Swing Trade Arbitrage Search

$SPRB:NASDAQ · Spruce Biosciences Inc

Sector: health

Conviction from: NASDAQ

52-week range: 38.06154.95

Rare endocrine disorder drug developer

2 tracked filer(s) hold this · 1 opened, 0 added, 0 trimmed in 30-JUN-2026

Aggregate 13FScore 60 — mean of 2 scored holder(s) · buyers (new/add) avg 75. Higher = the smart money in this name has the better track record.

Filer	13FScore	This quarter	Shares	Value	% of their book
Steve Cohen / Point72	75	New buy	28,278	$1,527,012	0.0%
Carlyle Group Inc. (auto-surfaced)	44	Holds (flat)	38,620	$2,085,493	0.0%

Beyond 13F — activists, insiders, politicians & research

Activist 13D filings daily digest →

Filed	Form	Activist	% of class	Conviction
2026-02-18	SCHEDULE 13D/A	Carlyle Group Inc.	4.7%	Med	filing

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-10-17.